These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort study. Sampaio Rocha-Filho PA; Magalhães JE; Fernandes Silva D; Carvalho Soares M; Marenga Arruda Buarque L; Dandara Pereira Gama M; Oliveira FAA Acta Neurol Belg; 2022 Jun; 122(3):725-733. PubMed ID: 35060095 [TBL] [Abstract][Full Text] [Related]
11. Spectrum of Neurological Manifestations in Covid-19: A Review. Garg RK Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664 [TBL] [Abstract][Full Text] [Related]
12. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry. García-Azorín D; Abildúa MJA; Aguirre MEE; Fernández SF; Moncó JCG; Guijarro-Castro C; Platas MG; Delgado FR; Andrés JML; Ezpeleta D; J Neurol Sci; 2021 Apr; 423():117283. PubMed ID: 33636661 [TBL] [Abstract][Full Text] [Related]
13. Neurological manifestations by sex and age group in COVID-19 inhospital patients. Pereira DN; Bicalho MAC; Jorge AO; Gomes AGDR; Schwarzbold AV; Araújo ALH; Cimini CCR; Ponce D; Rios DRA; Grizende GMS; Manenti ERF; Anschau F; Aranha FG; Bartolazzi F; Batista JDL; Tupinambás JT; Ruschel KB; Ferreira MAP; Paraíso PG; Araújo SF; Teixeira AL; Marcolino MS eNeurologicalSci; 2022 Sep; 28():100419. PubMed ID: 35935176 [TBL] [Abstract][Full Text] [Related]
14. Smell and Taste Dysfunction in Pediatric Patients With SARS-CoV-2 Infection. Púa Torrejón RC; Ordoño Saiz MV; González Alguacil E; Furones García M; Cantarín Extremera V; Ruiz Falcó ML; Soto Insuga V Pediatr Neurol; 2022 Nov; 136():28-33. PubMed ID: 36084419 [TBL] [Abstract][Full Text] [Related]
15. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study. Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026 [TBL] [Abstract][Full Text] [Related]
16. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209 [TBL] [Abstract][Full Text] [Related]
17. Neurological Manifestations in Hospitalized Geriatric Patients With COVID-19 at King Abdulaziz Medical City in Jeddah, Western Region, Saudi Arabia From 2020 to 2021: A Cross-Sectional Study. Marghalani YO; Kaneetah AH; Khan MA; Albakistani AA; Alzahrani SG; Kidwai A; Alansari KW; Alhamid HS; Alharbi MH; Attar A Cureus; 2023 Sep; 15(9):e45759. PubMed ID: 37876390 [TBL] [Abstract][Full Text] [Related]
18. Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19. Kacem I; Gharbi A; Harizi C; Souissi E; Safer M; Nasri A; Letaief H; Akkari M; Hechaichi A; Mrabet S; Dhaouadi S; Ben Djebara M; Derouiche S; Gargouri A; Chahed M; Ben Alaya N; Gouider R Neurol Sci; 2021 Jan; 42(1):39-46. PubMed ID: 33201360 [TBL] [Abstract][Full Text] [Related]
19. Neurological features and outcome in COVID-19: dementia can predict severe disease. Ghaffari M; Ansari H; Beladimoghadam N; Aghamiri SH; Haghighi M; Nabavi M; Mansouri B; Mehrpour M; Assarzadegan F; Hesami O; Sedaghat M; Farahbakhsh M; Lima BS J Neurovirol; 2021 Feb; 27(1):86-93. PubMed ID: 33417193 [TBL] [Abstract][Full Text] [Related]
20. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection. Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]